Related Experiment Videos
Angiocentric T-cell lymphoma in skin
S C Mayou1, A Anstey, A J Norton
1Department of Dermatology, St Bartholomew's Hospital, London.
Journal of the Royal Society of Medicine
|November 1, 1991
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Drug-induced photosensitivity: new insights into pathomechanisms and clinical variation through basic and applied science.
The British journal of dermatology·2016
Healthcare utilisation and cost among individuals with Long COVID in England and Wales: potential value of specialised post-COVID services.
Journal of the Royal Society of Medicine·2026
Competition and equity in NHS specialty training, 2021-2024: longitudinal cohort analysis of protected-characteristic outcomes.
Journal of the Royal Society of Medicine·2026
Industrial action and emergency department attendances in England, 2022-2024: a retrospective multicentre causal mediation analysis.
Journal of the Royal Society of Medicine·2026
Ethnic differences in specialty destinations in UK medicine: a repeated cross-sectional analysis of secondary data.
Journal of the Royal Society of Medicine·2026
Medical screening of elderly heads of state.
Journal of the Royal Society of Medicine·2026
Beyond expansion: workforce absence, administration and the persistence of NHS elective backlogs.
Journal of the Royal Society of Medicine·2026
ASO Editorial: Lymph Node Dissection in the Immunotherapy Era: Friend or Foe?
Annals of surgical oncology·2026
[Analysis of clinicopathological and immunological characteristics of patients with acquired immune deficiency syndrome-associated diffuse large B-cell lymphoma complicated by Talaromyces marneffei infection].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026
Real-World Experience With TRBC1 Immunohistochemistry Across Cutaneous T-Cell Lymphoma Subtypes:A Large Cohort Study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026